HIV Reservoirs PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download HIV Reservoirs PDF full book. Access full book title HIV Reservoirs by Guido Poli. Download full books in PDF and EPUB format.
Author: Guido Poli
Publisher:
ISBN: 9781071618714
Category : Electronic books
Languages : en
Pages : 451
Get Book Here
Book Description
This book details the development of methods and models to study the HIV-1 viral reservoir with the ultimate goal of achieving a functional cure of HIV infection. Chapters are divided into six parts covering cell lines, in vitro and ex vivo primary cell models of persistent infection, in vitro and ex vivo tissue-derived models, infected animal models human immune cells, methods of detection and analysis of the reservoir, and current approaches to achieve either a functional cure or cART-free long-term remission. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and cutting-edge, HIV Reservoirs: Methods and Protocols provides a comprehensive, updated collection of state-of-art methodologies and models to tackle the HIV-1 viral reservoir.
Author: Guido Poli
Publisher:
ISBN: 9781071618714
Category : Electronic books
Languages : en
Pages : 451
Get Book Here
Book Description
This book details the development of methods and models to study the HIV-1 viral reservoir with the ultimate goal of achieving a functional cure of HIV infection. Chapters are divided into six parts covering cell lines, in vitro and ex vivo primary cell models of persistent infection, in vitro and ex vivo tissue-derived models, infected animal models human immune cells, methods of detection and analysis of the reservoir, and current approaches to achieve either a functional cure or cART-free long-term remission. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols. Authoritative and cutting-edge, HIV Reservoirs: Methods and Protocols provides a comprehensive, updated collection of state-of-art methodologies and models to tackle the HIV-1 viral reservoir.
Author: Renee Marije Van Der Sluis
Publisher: Frontiers Media SA
ISBN: 2889666662
Category : Science
Languages : en
Pages : 111
Get Book Here
Book Description
Author: Guido Silvestri
Publisher: Springer
ISBN: 303002816X
Category : Medical
Languages : en
Pages : 253
Get Book Here
Book Description
This volume summarizes recent advances in understanding the mechanisms of HIV-1 latency, in characterizing residual viral reservoirs, and in developing targeted interventions to reduce HIV-1 persistence during antiretroviral therapy. Specific chapters address the molecular mechanisms that govern and regulate HIV-1 transcription and latency; assays and technical approaches to quantify viral reservoirs in humans and animal models; the complex interchange between viral reservoirs and the host immune system; computational strategies to model viral reservoir dynamics; and the development of therapeutic approaches that target viral reservoir cells. With contributions from an interdisciplinary group of investigators that cover a broad spectrum of subjects, from molecular virology to proof-of-principle clinical trials, this book is a valuable resource for basic scientists, translational investigators, infectious-disease physicians, individuals living with HIV/AIDS and the general public.
Author: Anabella Frost
Publisher: Hayle Medical
ISBN: 9781646475698
Category : Health & Fitness
Languages : en
Pages : 0
Get Book Here
Book Description
HIV is a virus that severely affects the immune system resulting in acquired immunodeficiency syndrome (AIDS). The treatment of HIV involves combination antiretroviral therapy (cART). This therapy suppresses HIV-1 replication, blocks transmission, and improves immune responses. cART is a lifelong treatment, and does not eliminate the virus while also having side effects. The focus in the treatment of HIV is the reactivation of HIV reservoirs for subsequent termination by viral cytopathic effects or host immunity. The most researched HIV reservoir is resting memory CD4+ T cells in peripheral blood and lymphoid tissues. The antiretroviral therapies have expanded significantly in the recent times and comprise five categories of antiretrovirals, including nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs) and entry inhibitors. This book unfolds the innovative aspects of HIV research which will be crucial for the progress of this field in the future. For someone with an interest and eye for detail, this book covers the most significant topics on HIV-AIDS and its treatment.
Author: Mark David Pankau
Publisher:
ISBN:
Category :
Languages : en
Pages : 96
Get Book Here
Book Description
Human immunodeficiency virus type 1 (HIV) has caused more than 35 million deaths world-wide and contributes significantly to the global burden of disease. Currently, the only effective treatment to suppress viral replication and prevent HIV transmission is combination antiretroviral therapy (ART), which prevents HIV from infecting new cells. Despite the efficacy of ART, long lived latently infected cells persist, with an estimated half-life of 44 months, and circulate throughout the infected host necessitating life-long treatment. These cells, known as the latent reservoir, contain an integrated form of the HIV genome (HIV DNA) that is transcriptionally silent, but can reactivate to produce virus. Therefore, interruption of ART inevitably leads to viral recrudescence stemming from the latent reservoir. Studying the latent reservoir is difficult because these cells contain no known biomarkers and do not always produce replication competent virus upon cellular activation. Additionally, latent reservoir cells are rare, and many proviral genomes contain defects that prevent them from producing replication competent virus. They do however confound efforts to measure the replication competent reservoir. Understanding the dynamics and correlates of reservoir seeding will be essential to develop novel cure strategies that target this latent reservoir. There is limited data on the dynamics of reservoir seeding throughout HIV infection, the impact of treatment interruption on reservoir size, and whether antibodies can play a role in limiting reservoir seeding. I focused my thesis on characterizing the seeding dynamics of latent reservoir cells containing HIV DNA (HIV DNA Reservoir) to better understand when the latent reservoir was generated and how it changed following treatment interruption. In the first part of this thesis I adapt, optimize, and validate a molecular based assay to quantitate HIV DNA from latently infected cells, as well as develop a novel cell line to detect replication competent HIV reactivated from latent reservoirs. In the second part of this thesis I demonstrate that the HIV DNA reservoir is limited by early ART and does not significantly increase following randomization to short treatment interruption in a cohort of Kenyan infants, suggesting that short treatment interruption studies may pose little risk to reservoir reseeding. I also examine the role of ADCC activity in preventing re-seeding of the latent reservoir and demonstrate that ADCC activity does not correlate with change in HIV DNA reservoir size following treatment interruption. Finally, I demonstrate that the HIV DNA reservoir is comprised mostly of viral variants circulating just prior to ART initiation, suggesting that during untreated infection the HIV DNA reservoir decays at a much faster rate than during suppressive ART. Together, these data demonstrate that the HIV DNA reservoir is limited by early ART, is not significantly reseeded with short treatment interruption, and that contrary to previous assumptions about reservoir dynamics, is decaying at a significantly faster rate pre-ART than after ART initiation, and suggest that targeting the HIV latent reservoir prior to early ART initiation may be an effective strategy to limit reservoir size, and that short treatment interruption can limit re-seeding of the latent reservoir.
Author: Constantinos Petrovas
Publisher: Frontiers Media SA
ISBN: 2889457583
Category :
Languages : en
Pages : 186
Get Book Here
Book Description
Currently, more than 36 million people are infected with HIV. Although the introduction of highly active anti-retroviral therapy (HAART) has led to substantial advances in the clinical management of HIV infected individuals, HAART cannot completely eliminate the virus. This is because CD4 T helper cells, harboring the virus, remain dormant reservoirs. These reservoirs are difficult to measure and are present even in HAART-treated HIV infected individuals with undetectable levels of HIV in the blood. A growing body of studies has revealed follicular helper (Tfh) CD4 T cells, a highly differentiated CD4 T cell population localized in immunologically sanctuary sites (follicle/germinal center), as a major reservoir of HIV. The present Frontiers in Immunology eBook compiles 16 timely review articles focusing on the dynamics of major follicular immune cell types in HIV/SIV infection and their potential role for disease pathogenesis and the viral persistence in the lymph node. This eBook provides a comprehensive presentation of recent published work on lymph node and especially Tfh cell dynamics in HIV infection and we hope that it will be useful for our further understanding of how such dynamics affect the interplay between virus and host as well as for the discovery of novel therapeutic targets in the fight against HIV.
Author: Guido Silvestri (Professor of pathology and laboratory medicine)
Publisher:
ISBN: 9783030028176
Category : HEALTH & FITNESS
Languages : en
Pages :
Get Book Here
Book Description
This volume summarizes recent advances in understanding the mechanisms of HIV-1 latency, in characterizing residual viral reservoirs, and in developing targeted interventions to reduce HIV-1 persistence during antiretroviral therapy. Specific chapters address the molecular mechanisms that govern and regulate HIV-1 transcription and latency; assays and technical approaches to quantify viral reservoirs in humans and animal models; the complex interchange between viral reservoirs and the host immune system; computational strategies to model viral reservoir dynamics; and the development of therapeutic approaches that target viral reservoir cells. With contributions from an interdisciplinary group of investigators that cover a broad spectrum of subjects, from molecular virology to proof-of-principle clinical trials, this book is a valuable resource for basic scientists, translational investigators, infectious-disease physicians, individuals living with HIV/AIDS and the general public.
Author: Daniel Donahue
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
"The major source of virus production during human immunodeficiency virus type 1 (HIV-1) infection is activated CD4 T-cells, although infection of some other cell types can also contribute to virus production. A viral reservoir is either a cell type or an anatomical site whose properties can result in the persistence of infectious virus for a longer time period than the primary source of virus production, and several different HIV-1 reservoirs are known to exist. The work presented in this thesis examines three different aspects of viral reservoirs in HIV-1 infection. The first part (Chapter 2) is an investigation of the role of long-lived virus-producing cells during antiretroviral therapy. Specifically, cell culture experiments were designed that have resulted in a further understanding of the inhibition of HIV-1 replication in viral reservoirs. The second and third parts of this thesis (Chapters 3 and 4) consider the role of latently infected CD4 T-cells in HIV-1 infection. Latently infected cells carry an HIV-1 genome that is integrated into the cellular chromatin and does not produce viruses, but that retains the capacity for infectious virus production in the future. These cells form the latent reservoir, which represents the major barrier to an HIV-1 cure and necessitates life-long antiretroviral therapy for infected individuals. The work presented in Chapter 3 demonstrates that it is possible to inhibit the establishment of latent infection in vitro, something that has not yet been achieved clinically. Chapter 4 considers the potential contribution of latent viruses to viral genetic diversity, and shows that latent viruses can contribute to the development of multidrug resistance. In summary, the work presented in this thesis provides for a greater understanding of the role of viral reservoirs in HIV-1 infection and of the ability of antiretroviral drugs to combat infection." --
Author: Anthony S. Fauci
Publisher: Springer Science & Business Media
ISBN: 3642608671
Category : Medical
Languages : en
Pages : 159
Get Book Here
Book Description
During the last 5 years, major advances have been made in our understanding of the pathogenesis of human immunodeficiency virus (HIV) disease and in the development of new potent antiviral agents. With regard to HIV pathogenesis, several recent observations have not only changed our perspectives of HIV disease, but have been critical for the design of therapeutic strategies.
Author: Atta-ur-Rahman
Publisher: Bentham Science Publishers
ISBN: 981146443X
Category : Medical
Languages : en
Pages : 222
Get Book Here
Book Description
Frontiers in Clinical Drug Research – HIV is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the book series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research. The fifth volume of this series features 5 chapters that cover these topics: - Clinical Eradication of Latent HIV Reservoirs: Where Are We Now? - HIV-1 Genotypic Drug Resistance Testing and Next-Generation Sequencing - Current and Promising Multiclass Drug Regimens and Long-Acting Formulation Drugs in HIV Therapy - Role of Nanotechnology in HIV Diagnosis and Prognosis - Preventive and Therapeutic Features of Combination Therapy for HIV.
